Position
WealthCollab, LLC in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.14K$46.30 → $33.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 86 | $3.98K | — | — | — | 0.0% |
| Q1 2026 | 86 | $2.85K | $33.08 | −$1.14K | $0 | 0.0% |